Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Child Immunization”

382 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 382 results

Post-approval studies (Phase 4)UnknownNCT00242047
What this trial is testing

Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.

Who this might be right for
Tuberculosis
University of Cape Town 12,000
Large-scale testing (Phase 3)WithdrawnNCT01676948
What this trial is testing

An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)

Who this might be right for
Systemic Juvenile Idiopathic Arthritis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00000815
What this trial is testing

A Phase II, Comparative Study of Seroconversion of Single-Dose and Two-Dose Measles Vaccination in HIV-Infected and HIV-Uninfected Children: A Multicenter Trial of the Pediatric AIDS Clinical Trials Group

Who this might be right for
HIV InfectionsMeasles
National Institute of Allergy and Infectious Diseases (NIAID) 270
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Large-scale testing (Phase 3)Ended earlyNCT00119743
What this trial is testing

A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine

Who this might be right for
Hepatitis A
GlaxoSmithKline 5,000
Post-approval studies (Phase 4)Study completedNCT04481243
What this trial is testing

Evaluate Pneumococcal Polysaccharide Vaccine Effectiveness in Children With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Mayo Clinic 29
Testing effectiveness (Phase 2)Study completedNCT01026974
What this trial is testing

Extension Study Evaluating Antibody Persistence and Safety, Tolerability and Immunogenicity of a Booster Dose of Novartis rMenB±OMV NZ Vaccine in Healthy UK Children Who Previously Received Three Doses of the Same Vaccine

Who this might be right for
Meningococcal Disease
Novartis Vaccines 120
Not applicableEnded earlyNCT06274359
What this trial is testing

Digital Storytelling to Reduce Pediatric Influenza Vaccination Disparities

Who this might be right for
Influenza
Denver Health and Hospital Authority 200
Large-scale testing (Phase 3)UnknownNCT01619462
What this trial is testing

Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children

Who this might be right for
PneumoniaMeningitisBacteraemia+2 more
Papua New Guinea Institute of Medical Research 200
Not applicableActive Not RecruitingNCT06079606
What this trial is testing

The Effects of Antibiotic Exposure in Early Infancy on Vaccine Responses

Who this might be right for
Immune ResponsesAntibiotic Treatment
Landspitali University Hospital 200
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Early research (Phase 1)Ended earlyNCT03859687
What this trial is testing

Trial of Antibody Responses by Vitamin Supplementation

Who this might be right for
Healthy Participants
St. Jude Children's Research Hospital 22
Post-approval studies (Phase 4)Study completedNCT00161122
What this trial is testing

Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)

Who this might be right for
Recurrent Upper and Lower Respiratory Tract Infections (RTIs)
UMC Utrecht 660
Not applicableUnknownNCT03373656
What this trial is testing

Vaccination for Children of H&O and Their Parents

Who this might be right for
VaccinationHematologic MalignancySolid Tumor, Childhood
Children's Cancer Group, China 300
Not applicableUnknownNCT06058429
What this trial is testing

Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

Who this might be right for
Polio
Sinovac Biotech Co., Ltd 233
Not applicableEnrolling By InvitationNCT06530875
What this trial is testing

Vaccination Hesitation in Expectant Mothers

Who this might be right for
Vaccine Hesitation
Yuzuncu Yil University 80
Not applicableStudy completedNCT03490045
What this trial is testing

Intervention to Reduce Diaper Need and Increase Use of Pediatric Preventive Care

Who this might be right for
Diaper DermatitisUrinary Tract InfectionsInfection+2 more
Yale University 77
Not applicableStudy completedNCT04203277
What this trial is testing

Improving Vaccinations for Young Children (IVY)

Who this might be right for
Vaccination Refusal
Vanderbilt University Medical Center 8
Post-approval studies (Phase 4)UnknownNCT04817917
What this trial is testing

Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province

Who this might be right for
Japanese EncephalitisVaccine Preventable DiseaseVaccine Reaction
Zhejiang Provincial Center for Disease Control and Prevention 712
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Load More Results